Early use of TLV | Delayed use of TLV | P value | |
---|---|---|---|
(n = 79) | (n = 67) | ||
Body mass index (kg/m2) | 21.7 ± 3.9 | 21.9 ± 4.2 | 0.778 |
NYHA class (II/III/IV) | 1/68/10 | 0/54/13 | 0.203 |
CS class (I/II/III) | 26/46/7 | 23/36/8 | 0.760 |
Systolic BP (mm Hg) on admission | 131.7 ± 28.0 | 128.6 ± 31.7 | 0.533 |
Diastolic BP (mm Hg) on admission | 69.7 ± 22.2 | 75.7 ± 17.9 | 0.073 |
Heart rate (bpm) | 89.0 ± 23.5 | 94.7 ± 28.8 | 0.195 |
AST (IU/L) | 62.4 ± 24.5 | 73.6 ± 24.9 | 0.750 |
ALT (IU/L) | 51.6 ± 21.8 | 62.0 ± 25.2 | 0.754 |
eGFR (ml/min/1.73 m2) | 49.0 ± 26.5 | 43.3 ± 21.5 | 0.156 |
Hemoglobin (g/dL) | 12.6 ± 2.2 | 12.0 ± 3.2 | 0.229 |
Brain natriuretic peptide (pg/mL) | 1153.2 ± 118.0 | 1529.3 ± 284.8 | 0.199 |
Ejection fraction (%) | 45.3 ± 17.6 | 43.2 ± 19.5 | 0.509 |
HFpEF (n, %) | 31, 39.2 | 25, 37.3 | 0.813 |
Length of hospital stay | 21.0 ± 13.0 | 33.0 ± 22.7 | < 0.001 |
Time until commencement of TLV from hospitalization | 2.5 ± 1.0 | 12.7 ± 13.3 | < 0.001 |
Length of hospital stay after initiation of TLV | 18.6 ± 13.1 | 20.3 ± 16.9 | 0.479 |